Cargando…
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113044/ http://dx.doi.org/10.1186/1758-2652-13-S4-P41 |
| _version_ | 1782205875325239296 |
|---|---|
| author | Ghosn, J Chermak, A Houssaini, A Peytavin, G Lambert-Niclot, S Eychenne, N Slama, L Brunet, A Duvivier, C Simon, A Marcelin, AG Flandre, P Katlama, C |
| author_facet | Ghosn, J Chermak, A Houssaini, A Peytavin, G Lambert-Niclot, S Eychenne, N Slama, L Brunet, A Duvivier, C Simon, A Marcelin, AG Flandre, P Katlama, C |
| author_sort | Ghosn, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113044 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130442011-06-13 Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study Ghosn, J Chermak, A Houssaini, A Peytavin, G Lambert-Niclot, S Eychenne, N Slama, L Brunet, A Duvivier, C Simon, A Marcelin, AG Flandre, P Katlama, C J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113044/ http://dx.doi.org/10.1186/1758-2652-13-S4-P41 Text en Copyright ©2010 Ghosn et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Ghosn, J Chermak, A Houssaini, A Peytavin, G Lambert-Niclot, S Eychenne, N Slama, L Brunet, A Duvivier, C Simon, A Marcelin, AG Flandre, P Katlama, C Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title | Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title_full | Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title_fullStr | Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title_full_unstemmed | Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title_short | Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study |
| title_sort | efficacy of once daily darunavir/ritonavir 800/100 mg in pi/r-experienced hiv-1 infected patients with suppressed hiv-1 replication: the radar study |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113044/ http://dx.doi.org/10.1186/1758-2652-13-S4-P41 |
| work_keys_str_mv | AT ghosnj efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT chermaka efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT houssainia efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT peytaving efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT lambertniclots efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT eychennen efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT slamal efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT bruneta efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT duvivierc efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT simona efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT marcelinag efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT flandrep efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy AT katlamac efficacyofoncedailydarunavirritonavir800100mginpirexperiencedhiv1infectedpatientswithsuppressedhiv1replicationtheradarstudy |